Coley Fluid

Coley Fluid is a modern reformulation of a historical cancer therapy called Coley Vaccine developed by Dr. William B. Coley that was an effective treatment for many forms of cancer including advanced breast cancer.

The authors of a 1982 study concluded five year survival rates of historical Coley Vaccine patients is indistinguishable from five-year survival of modern patients.

In 1999, researchers found ten-year survival was higher in historical Coley Vaccine patients compared to modern sarcoma, kidney and ovarian cancer patients.

Coley Fluid is manufactured by MBVax Bioscience Inc, Ancaster, Canada.

Template:WS